Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Oncothyreon, Inc. (ONTY)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ONTY
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Oncothyreon and OncoGenex: Room to Rise
VFC's Stock House
•
Oct 18
•
3 Comments
Dendreon: New Board Members Appointed, Things Have Never Looked Brighter
VFC's Stock House
•
Oct 12
•
5 Comments
Stock Watch: BDSI, ACTC.PK, ONTY
VFC's Stock House
•
Oct 11
•
8 Comments
Still a Lot of Potential in Dendreon and the Cancer Immunotherapy Market
VFC's Stock House
•
Sep 25
•
7 Comments
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Justin M. Hall
•
Sep 20
•
3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Justin M. Hall
•
Sep 11
•
23 Comments
More articles on ONTY »
Instablogs
Lucky 13 Buys 2.0
Tue October 20, 2009
•
Justin M. Hall
•
2 Comments
Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern
Fri September 18, 2009
•
Justin M. Hall
•
15 Comments
Lucky 13 Buys: \\\\ +43.87% //// in 9 Weeks
Wed September 16, 2009
•
Justin M. Hall
•
7 Comments
Write a post on ONTY
|
More Instablogs on ONTY »
Sentiment
What advice would you give to
ONTY?
123 characters left
What's your view of ONTY?
Make sure you include ONTY
140 characters left
|
Settings
Mike Havrilla
: $
DNDN
$
ONTY
$
IMUC.OB
$
CLDX
$
INO
Cancer Vaccines: Investing Opportunities beyond Dendreon (NASDAQ:
DNDN
)
http://hub.tm/?eizmf
Sat, Nov 28, 2009
Daniel Harrison
: (
ONTY
) now looks overbought unless there is a hard catalyst event.
Tue, Nov 10, 2009
Daniel Harrison
: Despite the rise, (
ONTY
) is still cheap @ around $4.50 a share: safe buy up until $5.20
Sat, Nov 07, 2009
Philip Davis
: $
ONTY
at $3.77, May $2.50 puts and calls can be sold for $2.20, net $1.27/1.89 so +100% if called away and half price if put to you.
Wed, Oct 28, 2009
More StockTalks on ONTY »